{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:33:31Z","timestamp":1792042411233,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["62993"],"award-info":[{"award-number":["62993"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["1338"],"award-info":[{"award-number":["1338"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06256-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:09:01Z","timestamp":1741082941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunogenic evaluation of LptD\u2009+\u2009LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae"],"prefix":"10.1186","volume":"23","author":[{"given":"Narjes","family":"Noori Goodarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Barzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Ajdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Badmasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-5765","authenticated-orcid":false,"given":"Mohammad Reza","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"6256_CR1","doi-asserted-by":"publisher","first-page":"e0009423","DOI":"10.1128\/cmr.00094-23","volume":"37","author":"E Williams","year":"2024","unstructured":"Williams E, Seib KL, Fairley CK, Pollock GL, Hocking JS, McCarthy JS, Williamson DA. Neisseria gonorrhoeae vaccines: a contemporary overview. Clin Microbiol Rev. 2024;37:e0009423.","journal-title":"Clin Microbiol Rev"},{"key":"6256_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587\u2013613.","journal-title":"Clin Microbiol Rev"},{"key":"6256_CR3","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1512757","volume":"374","author":"H Fifer","year":"2016","unstructured":"Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, Unemo M. Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med. 2016;374:2504\u20136.","journal-title":"N Engl J Med"},{"key":"6256_CR4","unstructured":"Multi-drug resistant gonorrhea [https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multi-drug-resistant-gonorrhoea]."},{"key":"6256_CR5","unstructured":"WHO guidelines for the treatment of Neisseria gonorrhoeae. [https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/gonorrhoea-treatment-guidelines\/en\/]."},{"key":"6256_CR6","unstructured":"Treatment G. and Care [https:\/\/www.cdc.gov\/std\/gonorrhea\/treatment.htm]."},{"key":"6256_CR7","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","volume":"69","author":"S St Cyr","year":"2020","unstructured":"St Cyr S, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K, Torrone E, Weinstock H, Kersh EN, Thorpe P. Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1911\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6256_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3201\/eid2206.152091","volume":"22","author":"R Gianecini","year":"2016","unstructured":"Gianecini R, Oviedo C, Stafforini G, Galarza P. Neisseria gonorrhoeae resistant to ceftriaxone and cefixime, Argentina. Emerg Infect Dis. 2016;22:1139\u201341.","journal-title":"Emerg Infect Dis"},{"key":"6256_CR9","doi-asserted-by":"crossref","unstructured":"Ber\u00e7ot B, Cam\u00e9l\u00e9na F, M\u00e9rim\u00e8che M, Jacobsson S, Sbaa G, Mainardis M, Valin C, Molina JM, B\u00e9b\u00e9ar C, Chazelle E et al. Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022. Euro Surveill 2022, 27.","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200899"},{"key":"6256_CR10","doi-asserted-by":"crossref","unstructured":"Pleininger S, Indra A, Golparian D, Heger F, Schindler S, Jacobsson S, Heidler S, Unemo M. Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus Azithromycin in Austria, April 2022. Euro Surveill 2022, 27.","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455"},{"key":"6256_CR11","doi-asserted-by":"crossref","unstructured":"Day M, Pitt R, Mody N, Saunders J, Rai R, Nori A, Church H, Mensforth S, Corkin H, Jones J et al. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the united Kingdom, December 2021 to June 2022. Euro Surveill 2022, 27.","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200803"},{"key":"6256_CR12","unstructured":"Report on global sexually transmitted infection surveillance. [https:\/\/www.who.int\/reproductivehealth\/publications\/stis-surveillance-2018\/en\/]."},{"key":"6256_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24:85\u201392.","journal-title":"Int J STD AIDS"},{"key":"6256_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","volume":"17","author":"V Don\u00e0","year":"2017","unstructured":"Don\u00e0 V, Low N, Golparian D, Unemo M. Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. Expert Rev Mol Diagn. 2017;17:845\u201359.","journal-title":"Expert Rev Mol Diagn"},{"key":"6256_CR15","doi-asserted-by":"crossref","unstructured":"Kozak M, Hu J. The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development. Vaccines (Basel) 2023, 11.","DOI":"10.3390\/vaccines11030695"},{"key":"6256_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2021.01.001","volume":"170","author":"J Pollet","year":"2021","unstructured":"Pollet J, Chen WH, Strych U. Recombinant protein vaccines, a proven approach against coronavirus pandemics. Adv Drug Deliv Rev. 2021;170:71\u201382.","journal-title":"Adv Drug Deliv Rev"},{"key":"6256_CR17","unstructured":"Feing X. Advantage and potential of Recombinant vaccines. J Vaccines Vaccination 2023:519."},{"key":"6256_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12934-022-01929-8","volume":"21","author":"MT de Pinho Favaro","year":"2022","unstructured":"de Pinho Favaro MT, Atienza-Garriga J, Mart\u00ednez-Torr\u00f3 C, Parlad\u00e9 E, V\u00e1zquez E, Corchero JL, Ferrer-Miralles N, Villaverde A. Recombinant vaccines in 2022: a perspective from the cell factory. Microb Cell Fact. 2022;21:203.","journal-title":"Microb Cell Fact"},{"key":"6256_CR19","doi-asserted-by":"publisher","first-page":"105449","DOI":"10.1016\/j.meegid.2023.105449","volume":"112","author":"N Noori Goodarzi","year":"2023","unstructured":"Noori Goodarzi N, Ajdary S, Yekaninejad MS, Fereshteh S, Pourmand MR, Badmasti F. Reverse vaccinology approaches to introduce promising Immunogenic and drug targets against antibiotic-resistant Neisseria gonorrhoeae: thinking outside the box in current prevention and treatment. Infect Genet Evol. 2023;112:105449.","journal-title":"Infect Genet Evol"},{"key":"6256_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-022-29459-2","volume":"13","author":"M Botte","year":"2022","unstructured":"Botte M, Ni D, Schenck S, Zimmermann I, Chami M, Bocquet N, Egloff P, Bucher D, Trabuco M, Cheng RKY, et al. Cryo-EM structures of a LptDE transporter in complex with Pro-macrobodies offer insight into lipopolysaccharide translocation. Nat Commun. 2022;13:1826.","journal-title":"Nat Commun"},{"key":"6256_CR21","doi-asserted-by":"publisher","first-page":"17981","DOI":"10.1074\/jbc.R117.802512","volume":"292","author":"P Sperandeo","year":"2017","unstructured":"Sperandeo P, Martorana AM, Polissi A. The lipopolysaccharide transport (Lpt) machinery: A nonconventional transporter for lipopolysaccharide assembly at the outer membrane of Gram-negative bacteria. J Biol Chem. 2017;292:17981\u201390.","journal-title":"J Biol Chem"},{"key":"6256_CR22","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","volume":"15","author":"RA Zielke","year":"2016","unstructured":"Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK, Jerse AE, Unemo M, Sikora AE. Proteomics-driven antigen discovery for development of vaccines against gonorrhea. Mol Cell Proteom. 2016;15:2338\u201355.","journal-title":"Mol Cell Proteom"},{"key":"6256_CR23","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.1128\/JB.186.22.7811-7814.2004","volume":"186","author":"KA Cloud","year":"2004","unstructured":"Cloud KA, Dillard JP. Mutation of a single lytic transglycosylase causes aberrant septation and inhibits cell separation of Neisseria gonorrhoeae. J Bacteriol. 2004;186:7811\u20134.","journal-title":"J Bacteriol"},{"key":"6256_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/mdr.2012.0001","volume":"18","author":"YA Chan","year":"2012","unstructured":"Chan YA, Hackett KT, Dillard JP. The lytic transglycosylases of Neisseria gonorrhoeae. Microb Drug Resist. 2012;18:271\u20139.","journal-title":"Microb Drug Resist"},{"key":"6256_CR25","doi-asserted-by":"publisher","first-page":"1248613","DOI":"10.3389\/fimmu.2023.1248613","volume":"14","author":"T Belcher","year":"2023","unstructured":"Belcher T, Rollier CS, Dold C, Ross JDC, MacLennan CA. Immune responses to Neisseria gonorrhoeae and implications for vaccine development. Front Immunol. 2023;14:1248613.","journal-title":"Front Immunol"},{"key":"6256_CR26","doi-asserted-by":"publisher","first-page":"e0038822","DOI":"10.1128\/msphere.00388-22","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hammer LA, Daamen J, Stork M, Egilmez NK, Russell MW. Microencapsulated IL-12 drives genital tract immune responses to intranasal gonococcal outer membrane vesicle vaccine and induces resistance to vaginal infection with diverse strains of Neisseria gonorrhoeae. mSphere. 2023;8:e0038822.","journal-title":"mSphere"},{"key":"6256_CR27","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/mi.2017.11","volume":"10","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hammer LA, Liu W, Hobbs MM, Zielke RA, Sikora AE, Jerse AE, Egilmez NK, Russell MW. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model. Mucosal Immunol. 2017;10:1594\u2013608.","journal-title":"Mucosal Immunol"},{"key":"6256_CR28","doi-asserted-by":"crossref","unstructured":"Roe SK, Felter B, Zheng B, Ram S, Wetzler LM, Garges E, Zhu T, Genco CA, Massari P. In vitro Pre-Clinical evaluation of a gonococcal trivalent candidate vaccine identified by transcriptomics. Vaccines (Basel) 2023, 11.","DOI":"10.3390\/vaccines11121846"},{"key":"6256_CR29","doi-asserted-by":"crossref","unstructured":"Green MR, Sambrook J. Cloning and Transformation with Plasmid Vectors. Cold Spring Harb Protoc. 2021;2021.","DOI":"10.1101\/pdb.top101170"},{"key":"6256_CR30","doi-asserted-by":"publisher","first-page":"105063","DOI":"10.1016\/j.micpath.2021.105063","volume":"158","author":"F Badmasti","year":"2021","unstructured":"Badmasti F, Habibi M, Firoozeh F, Fereshteh S, Bolourchi N, Goodarzi NN. The combination of CipA and PBP-7\/8 proteins contribute to the survival of C57BL\/6 mice from sepsis of Acinetobacter baumannii. Microb Pathog. 2021;158:105063.","journal-title":"Microb Pathog"},{"key":"6256_CR31","unstructured":"QIAexpressionist A. A handbook for high-level expression and purification of 6xhis-tagged proteins. Qiagen. 2002:1-125."},{"key":"6256_CR32","doi-asserted-by":"crossref","unstructured":"Hung MC, Heckels JE, Christodoulides M. The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential. mBio 2013, 4.","DOI":"10.1128\/mBio.00041-13"},{"key":"6256_CR33","doi-asserted-by":"crossref","unstructured":"Almonacid-Mendoza HL, Humbert MV, Dijokaite A, Cleary DW, Soo Y, Hung MC, Orr CM, Machelett MM, Tews I, Christodoulides M. Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci. mSphere. 2018;3.","DOI":"10.1128\/mSphere.00331-18"},{"key":"6256_CR34","doi-asserted-by":"crossref","unstructured":"Yano J, Fidel PL Jr. Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. J Vis Exp 2011.","DOI":"10.3791\/3382-v"},{"key":"6256_CR35","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s10989-020-10056-0","volume":"26","author":"I Rasooli","year":"2020","unstructured":"Rasooli I, Abdolhamidi R, Jahangiri A, Darvish Alipour Astaneh S. Outer membrane protein, Oma87 prevents Acinetobacter baumannii infection. Int J Pept Res Ther. 2020;26:2653\u201360.","journal-title":"Int J Pept Res Ther"},{"key":"6256_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-0716-1900-1_19","volume":"2414","author":"EA Semchenko","year":"2022","unstructured":"Semchenko EA, Jen FE, Jennings MP, Seib KL. Assessment of serum bactericidal and opsonophagocytic activity of antibodies to gonococcal vaccine targets. Methods Mol Biol. 2022;2414:363\u201372.","journal-title":"Methods Mol Biol"},{"key":"6256_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/apm.12252","volume":"122","author":"A Keyhani","year":"2014","unstructured":"Keyhani A, Riazi-Rad F, Pakzad SR, Ajdary S. Human polymorphonuclear leukocytes produce cytokines in response to leishmania major promastigotes. Apmis. 2014;122:891\u20137.","journal-title":"Apmis"},{"key":"6256_CR38","doi-asserted-by":"crossref","unstructured":"Jefferson A, Smith A, Fasinu PS, Thompson DK. Sexually transmitted Neisseria gonorrhoeae Infections-Update on drug treatment and vaccine development. Med (Basel) 2021, 8.","DOI":"10.3390\/medicines8020011"},{"key":"6256_CR39","doi-asserted-by":"publisher","first-page":"102633","DOI":"10.1016\/j.jddst.2021.102633","volume":"64","author":"P Zamani","year":"2021","unstructured":"Zamani P, Alavizadeh SH, Fakhraee F, Badiee A, Jalali SA, Chavoshian O, Khamesipour A, Kheiri MT, Mahboudi F, Jaafari MR. Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model. J Drug Deliv Sci Technol. 2021;64:102633.","journal-title":"J Drug Deliv Sci Technol"},{"key":"6256_CR40","doi-asserted-by":"publisher","first-page":"e081675","DOI":"10.1136\/bmjopen-2023-081675","volume":"14","author":"KL Seib","year":"2024","unstructured":"Seib KL, Donovan B, Thng C, Lewis DA, McNulty A, Fairley CK, Yeung B, Jin F, Fraser D, Bavinton BR, et al. Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol. BMJ Open. 2024;14:e081675.","journal-title":"BMJ Open"},{"key":"6256_CR41","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.vaccine.2023.01.053","volume":"42","author":"Y Lyu","year":"2024","unstructured":"Lyu Y, Choong A, Chow EPF, Seib KL, Marshall HS, Unemo M, de Voux A, Wang B, Miranda AE, Gottlieb SL, et al. Vaccine value profile for Neisseria gonorrhoeae. Vaccine. 2024;42:S42\u201369.","journal-title":"Vaccine"},{"key":"6256_CR42","doi-asserted-by":"crossref","unstructured":"Marjuki H, Topaz N, Joseph SJ, Gernert KM, Kersh EN, Wang X. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine. mBio. 2019;10.","DOI":"10.1128\/mBio.01668-19"},{"key":"6256_CR43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","volume":"69","author":"EA Semchenko","year":"2019","unstructured":"Semchenko EA, Tan A, Borrow R, Seib KL. The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae. Clin Infect Dis. 2019;69:1101\u201311.","journal-title":"Clin Infect Dis"},{"key":"6256_CR44","doi-asserted-by":"crossref","unstructured":"Voter AF, Callaghan MM, Tippana R, Myong S, Dillard JP, Keck JL. Antigenic variation in Neisseria gonorrhoeae occurs independently of RecQ-Mediated unwinding of the pile G quadruplex. J Bacteriol 2020, 202.","DOI":"10.1128\/JB.00607-19"},{"key":"6256_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.0300-9475.2004.01362.x","volume":"59","author":"TE Michaelsen","year":"2004","unstructured":"Michaelsen TE, Kolberg J, Aase A, Herstad TK, H\u00f8iby EA. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand J Immunol. 2004;59:34\u20139.","journal-title":"Scand J Immunol"},{"key":"6256_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000049504","volume":"126","author":"AW Wheeler","year":"2001","unstructured":"Wheeler AW, Marshall JS, Ulrich JT. A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Int Arch Allergy Immunol. 2001;126:135\u20139.","journal-title":"Int Arch Allergy Immunol"},{"key":"6256_CR47","doi-asserted-by":"crossref","unstructured":"Sen-Kilic E, Blackwood CB, Huckaby AB, Horspool AM, Weaver KL, Malkowski AC, Witt WT, Bevere JR, Damron FH, Barbier M. Defining the mechanistic correlates of protection conferred by Whole-Cell vaccination against Pseudomonas aeruginosa acute murine pneumonia. Infect Immun 2021, 89.","DOI":"10.1128\/IAI.00451-20"},{"key":"6256_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/CVI.00600-12","volume":"20","author":"SM Noh","year":"2013","unstructured":"Noh SM, Turse JE, Brown WC, Norimine J, Palmer GH. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge. Clin Vaccine Immunol. 2013;20:651\u20136.","journal-title":"Clin Vaccine Immunol"},{"key":"6256_CR49","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1021\/acs.analchem.1c00420","volume":"93","author":"C Malburet","year":"2021","unstructured":"Malburet C, Leclercq L, Cotte JF, Thiebaud J, Marco S, Nicola\u00ef MC, Cottet H. Antigen-Adjuvant interactions in vaccines by Taylor dispersion analysis: size characterization and binding parameters. Anal Chem. 2021;93:6508\u201315.","journal-title":"Anal Chem"},{"key":"6256_CR50","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/14760584.2021.1981865","volume":"20","author":"M Christodoulides","year":"2021","unstructured":"Christodoulides M, Humbert MV, Heckels JE. The potential utility of liposomes for Neisseria vaccines. Expert Rev Vaccines. 2021;20:1235\u201356.","journal-title":"Expert Rev Vaccines"},{"key":"6256_CR51","doi-asserted-by":"publisher","first-page":"e25733","DOI":"10.1016\/j.heliyon.2024.e25733","volume":"10","author":"L Xia","year":"2024","unstructured":"Xia L, Lu Q, Wang X, Jia C, Zhao Y, Wang G, Yang J, Zhang N, Min X, Huang J, Huang M. Characterization of protective immune responses against Neisseria gonorrhoeae induced by intranasal immunization with adhesion and penetration protein. Heliyon. 2024;10:e25733.","journal-title":"Heliyon"},{"key":"6256_CR52","doi-asserted-by":"crossref","unstructured":"Zhu T, McClure R, Harrison OB, Genco C, Massari P. Integrated bioinformatic analyses and immune characterization of new Neisseria gonorrhoeae vaccine antigens expressed during natural mucosal infection. Vaccines (Basel) 2019, 7.","DOI":"10.3390\/vaccines7040153"},{"key":"6256_CR53","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","volume":"73","author":"GA Price","year":"2005","unstructured":"Price GA, Russell MW, Cornelissen CN. Intranasal administration of Recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect Immun. 2005;73:3945\u201353.","journal-title":"Infect Immun"},{"key":"6256_CR54","doi-asserted-by":"publisher","first-page":"840122","DOI":"10.3389\/fcimb.2022.840122","volume":"12","author":"M Heydarian","year":"2022","unstructured":"Heydarian M, R\u00fchl E, Rawal R, Kozjak-Pavlovic V. Tissue models for Neisseria gonorrhoeae Research-From 2D to 3D. Front Cell Infect Microbiol. 2022;12:840122.","journal-title":"Front Cell Infect Microbiol"},{"key":"6256_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmicb.2011.00107","volume":"2","author":"A Jerse","year":"2011","unstructured":"Jerse A, Wu H, Packiam M, Vonck R, Begum A, Garvin L. Estradiol-Treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections. Front Microbiol. 2011;2:107.","journal-title":"Front Microbiol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06256-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:09:10Z","timestamp":1741082950000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06256-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6256"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06256-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Research Ethics Committee of the Tehran University of Medical Sciences (approval ID: IR.TUMS.SPH.REC.1403.073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}